{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T01:06:27Z","timestamp":1790643987137,"version":"4.1.0"},"reference-count":11,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2018,8,16]],"date-time":"2018-08-16T00:00:00Z","timestamp":1534377600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Microbiol Infect Dis"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1007\/s10096-018-3338-z","type":"journal-article","created":{"date-parts":[[2018,8,16]],"date-time":"2018-08-16T04:36:16Z","timestamp":1534394176000},"page":"2021-2025","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Ceftibuten plus amoxicillin-clavulanic acid for oral treatment of urinary tract infections with ESBL producing E. coli and K. pneumoniae: a retrospective observational case-series"],"prefix":"10.1007","volume":"37","author":[{"given":"James","family":"Cohen Stuart","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurine","family":"Leverstein - Van Hall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Willemijn","family":"Kortmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Verlind","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frouke","family":"Mulder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jelle","family":"Scharringa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ad","family":"Fluit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miquel","family":"Ekkelenkamp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,8,16]]},"reference":[{"issue":"3","key":"3338_CR1","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1128\/JCM.06248-11","volume":"50","author":"JD Campbell","year":"2012","unstructured":"Campbell JD, Lewis JS, McElmeel ML, Fulcher LC, Jorgensen JH (2012) Detection of favorable oral cephalosporin-clavulanate interactions by in vitro disk approximation susceptibility testing of extended-spectrum-Beta-lactamase-producing members of the enterobacteriaceae. J Clin Microbiol 50(3):1023\u20131026","journal-title":"J Clin Microbiol"},{"issue":"Suppl 1","key":"3338_CR2","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1111\/j.1469-0691.2007.01858.x","volume":"14","author":"DM Livermore","year":"2008","unstructured":"Livermore DM, Hope R, Mushtaq S, Warner M (2008) Orthodox and unorthodox clavulanate combinations against extended-spectrum beta-lactamase producers. Clin Microbiol Infect 14(Suppl 1):189\u2013193","journal-title":"Clin Microbiol Infect"},{"issue":"3","key":"3338_CR3","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1128\/AAC.01519-08","volume":"53","author":"V Prakash","year":"2009","unstructured":"Prakash V, Lewis JS, Herrera ML, Wickes BL, Jorgensen JH (2009) Oral and parenteral therapeutic options for outpatient urinary infections caused by enterobacteriaceae producing CTX-M extended-spectrum beta-lactamases. Antimicrob Agents Chemother 53(3):1278\u20131280","journal-title":"Antimicrob Agents Chemother"},{"key":"3338_CR4","first-page":"356","volume":"37","author":"GM Voets","year":"2011","unstructured":"Voets GM, Fluit AC, Scharringa J, Cohen Stuart J, Leverstein-van Hall MA (2011) A set of multiplex PCRs for genotypic detection of extended-spectrum beta-lactamases, carbapenemases, plasmid-mediated AmpC beta-lactamases and OXA beta-lactamases. IntJAntimicrobAgents 37:356\u2013359","journal-title":"IntJAntimicrobAgents"},{"issue":"5","key":"3338_CR5","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/j.ijantimicag.2015.08.011","volume":"46","author":"K Bush","year":"2015","unstructured":"Bush K (2015 Nov) A resurgence of \u03b2-lactamase inhibitor combinations effective against multidrug-resistant Gram-negative pathogens. Int J Antimicrob Agents 46(5):483\u2013493","journal-title":"Int J Antimicrob Agents"},{"issue":"5","key":"3338_CR6","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.ijantimicag.2010.11.028","volume":"37","author":"DM Livermore","year":"2011","unstructured":"Livermore DM, Mushtaq S, Nguyen T, Warner M (2011) Strategies to overcome extended-spectrum \u03b2-lactamases (ESBLs) and AmpC \u03b2-lactamases in shigellae. Int J Antimicrob Agents 37(5):405\u2013409","journal-title":"Int J Antimicrob Agents"},{"issue":"1","key":"3338_CR7","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/S0924-8579(00)00319-8","volume":"17","author":"M Perilli","year":"2001","unstructured":"Perilli M, Segatore B, Franceschini N, Gizzi G, Mancinelli A, Caravelli B et al (2001) Ceftibuten stability to active-site serine and metallo-beta-lactamases. Int J Antimicrob Agents 17(1):45\u201350","journal-title":"Int J Antimicrob Agents"},{"issue":"8","key":"3338_CR8","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1007\/s10096-011-1183-4","volume":"30","author":"M T\u00e4rnberg","year":"2011","unstructured":"T\u00e4rnberg M, Ostholm-Balkhed A, Monstein HJ, H\u00e4llgren A, Hanberger H, Nilsson LE (2011) In vitro activity of beta-lactam antibiotics against CTX-M-producing Escherichia coli. Eur J Clin Microbiol Infect Dis 30(8):981\u2013987","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"2","key":"3338_CR9","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1128\/AAC.39.2.356","volume":"39","author":"C Lin","year":"1995","unstructured":"Lin C, Radwanski E, Affrime M, Cayen MN (1995) Multiple-dose pharmacokinetics of ceftibuten in healthy volunteers. Antimicrob Agents Chemother 39(2):356\u2013358","journal-title":"Antimicrob Agents Chemother"},{"key":"3338_CR10","doi-asserted-by":"crossref","unstructured":"D Adam, I de Visser, and P Koeppe. Pharmacokinetics of amoxicillin and clavulanic acid administered alone and in combination. Antimicrob Agents Chemother 1982; 22(3): 353\u2013357","DOI":"10.1128\/AAC.22.3.353"},{"issue":"6","key":"3338_CR11","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1093\/jac\/dkl102","volume":"57","author":"PR Lagac\u00e9-Wiens","year":"2006","unstructured":"Lagac\u00e9-Wiens PR, Nichol KA, Nicolle LE, DeCorby M, McCracken M, Mulvey MR et al (2006) Treatment of lower urinary tract infection caused by multidrug-resistant extended-spectrum-beta-lactamase-producing Escherichia coli with amoxicillin\/clavulanate: case report and characterization of the isolate. J Antimicrob Chemother 57(6):1262\u20131263","journal-title":"J Antimicrob Chemother"}],"container-title":["European Journal of Clinical Microbiology & Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10096-018-3338-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-018-3338-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-018-3338-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,15]],"date-time":"2019-08-15T19:15:23Z","timestamp":1565896523000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10096-018-3338-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,16]]},"references-count":11,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["3338"],"URL":"https:\/\/doi.org\/10.1007\/s10096-018-3338-z","relation":{},"ISSN":["0934-9723","1435-4373"],"issn-type":[{"value":"0934-9723","type":"print"},{"value":"1435-4373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,16]]},"assertion":[{"value":"7 June 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 July 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 August 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not required.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"For this type of study, formal consent is not required.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}